US Stock MarketDetailed Quotes
INVO INVO Bioscience
- 0.9800
- -0.0001-0.01%
Close Apr 26 16:00 ET
- 0.9801
- +0.0001+0.01%
Post 19:51 ET
2.69MMarket Cap-191P/E (TTM)
1.0900High0.9081Low254.23KVolume0.9400Open0.9801Pre Close249.03KTurnover9.36%Turnover RatioLossP/E (Static)2.74MShares8.600052wk High-0.53P/B2.66MFloat Cap0.500052wk Low--Dividend TTM2.71MShs Float246.0000Historical High--Div YieldTTM18.56%Amplitude0.5000Historical Low0.9790Avg Price1Lot Size
About INVO Bioscience Company
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.
Company Profile
SymbolINVO
Company NameINVO Bioscience
Listing DateNov 13, 2020
Issue Price3.20
Founded2007
CEOMr. Steven M. Shum
MarketNASDAQ
Employees30
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5582 Broadcast Court
CitySarasota
ProvinceFlorida
CountryUnited States of America
Zip Code34240
Phone1-978-878-9505
Company Executives
- Name
- Position
- Salary
- Steven M. Shum
- Director and Chief Executive Officer
- 502.00K
- Andrea Goren
- Chief Financial Officer and Principal Accounting Officer
- 595.82K
- Michael J. Campbell
- Chief Operating Officer and Vice President, Business Development
- 330.00K
- Rebecca Messina
- Independent Director
- 100.89K
- Matthew K. Szot
- Independent Director
- 128.55K
- Barbara Ryan
- Independent Director
- 102.52K
- Trent D. Davis
- Independent Director
- 106.11K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg